Two, patterns of clinical recovery in Guillain-Barre syndrome with IgG anti-GM1 antibody

Neurology

Volumn 51, Issue 6, 1998, Pages 1656-1660

  Kuwabara, S ^a   Asahina, M ^a   Koga, M ^b   Mori, M ^a   Yuki, N ^b   Hattori, T ^a  

^a CHIBA UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ALLOTYPE; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN GM1 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; DEMYELINATION; DIAGNOSTIC VALUE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE FIBER DEGENERATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0031648841     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.6.1656     Document Type: Article

References (17)

1. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126.
2. McKahnn GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342.
3. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China: the spectrum of neuropathologic changes in clinically defined cases. Brain 1995;118:577-595.
4. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-1902.
5. Visser LH, Van der Meché FGA, Van Doorn PA, et al. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 1995;118:841-847.
6. Ilyas AA, Mithen FA, Dalakas MC, et al. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1992;107: 111-121.
7. Van den Berg LH, Marrink J, deJager AEJ, et al. Anti-GM1 antibodies in patients with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1992;55:8-11.
8. Enders U, Karch H, Toyka K, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-144.
9. Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816.
10. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
11. Gregson NA, Koblar S, Hughes RAC. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. QJM 1993;86:111-117.
12. Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL. Serum antibodies to GM1, GD1b, peripheral myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol 1993;34:130-135.
13. Ho TW, Li CY, Cornblath DR, et al. Patterns of clinical recovery in the Guillain-Barré syndrome. Neurology 1997;48:695-700.
14. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(suppl):S21-S24.
15. Yuki N, Tagawa Y, Irie F, Hirabayashi Y, Handa S. Close correlation of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α. J Neuroimmunol 1997;74:30-34.
16. + currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-442.
17. Hafer-Macko C, Hsieh S-T, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-644.